Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,755Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Temodar

PharmaCompass

01

Brand Name : Temodar

Temozolomide

arrow
Antibody Engineering
Not Confirmed

Brand Name : Temodar

arrow
Antibody Engineering
Not Confirmed

Temozolomide

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 350

2014 Revenue in Millions : 312

Growth (%) : -12%

blank

02

Brand Name : Temodar

Temozolomide

arrow
Antibody Engineering
Not Confirmed

Brand Name : Temodar

arrow
Antibody Engineering
Not Confirmed

Temozolomide

Main Therapeutic Indication : Oncology

Currency : USD

2014 Revenue in Millions : -50.60%

2013 Revenue in Millions :

Growth (%) :

blank

03

Brand Name : Temodar

Temozolomide

arrow
Antibody Engineering
Not Confirmed

Brand Name : Temodar

arrow
Antibody Engineering
Not Confirmed

Temozolomide

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 283

2015 Revenue in Millions : 313

Growth (%) : -10

blank

04

Brand Name : Temodar

Temozolamide

arrow
Antibody Engineering
Not Confirmed

Brand Name : Temodar

arrow
Antibody Engineering
Not Confirmed

Temozolamide

Main Therapeutic Indication : Others

Currency : USD

2017 Revenue in Millions : 271

2016 Revenue in Millions : 283

Growth (%) : -4

blank

05

Brand Name : Temodar

Temozolomide

arrow
Antibody Engineering
Not Confirmed

Brand Name : Temodar

arrow
Antibody Engineering
Not Confirmed

Temozolomide

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 214

2017 Revenue in Millions : 271

Growth (%) : -21%

blank